Skin cancer

Cancer patient receives chemotherapy via IV
#Clinical trial #Skin cancer

Therapeutic could help skin cancer patients avoid surgery 

A new therapeutic could help patients with non-melanoma skin cancer avoid immediate surgery, data shows.  The Phase II SkinJect dataset, released by biotech company Medicus Pharma, shows microneedle-mediated delivery of doxorubicin led to a response rate of approximately 80%.  The study, which compared doxorubicin compared with a… Read More

#Cancer Research #News

Cancer cells
#Cancer research #Institute of Cancer Research #Skin cancer

SLC7A11 inhibitors could remove skin cancer’s protective armour

Scientists have uncovered a protein that acts like a ‘suit of armour’ for cancer cells, shielding them from hostile environments and allowing one of the deadliest forms of skin cancer to spread through the body. A team of researchers from The Institute of Cancer Research, London, has identified that a… Read More

#Cancer Research #News

Melanoma or skin cancer
#Immunotherapy #Oncology #Skin cancer #University of Queensland

Cancer immunotherapy reduces skin cancers by 65%

University of Queensland researchers have discovered that immunotherapy, when used to treat people with advanced cancers, also helps reduce sunspots and skin cancers by at least 65%.  Over 12 months, researchers monitored 23 patients receiving immunotherapy for unrelated cancers and found the treatment also targeted cancerous and… Read More

#Cancer Research #News

Melanoma or skin cancer
#3D imaging #Cancer drug targets #Drug targets #Oncology #Skin cancer #The Institute of Cancer Research

Discovery reveals two potential drug targets against skin cancer

Scientists have discovered how skin cancer cells shapeshift based on their environment – enabling them to spread through the body and cause a metastatic cancer. The discovery of two genes responsible for sensing the environment and adapting cell shape could offer potential new drug targets to… Read More

#Cancer Research #Editor's Choice #News

T cells attacking cancer
#CAR-T #Elicera Therapeutics #Lung cancer #Oncology #Partnership #Skin cancer #T cell receptor (TCR)

Collaborators investigate novel T-cell receptor therapy

Elicera Therapeutics has entered a Material Transfer Agreement (MTA) with a prominent US cancer centre to evaluate the enhancing effect of the iTANK-technology in a novel T-cell receptor therapy targeting skin cancer and lung cancer. Elicera Therapeutics will make parts of its technology iTANK available to… Read More

#Cancer Research #News

Vitamin supplements
#Cancer research #Immunotherapy #Melanoma #Oncology #Skin cancer

Vitamin D levels impact response to immunotherapy in melanoma

New research indicates that for patients with advanced skin cancer, it may be important to maintain normal vitamin D levels when receiving treatment with immune checkpoint inhibitors. The findings are published in CANCER, a peer-reviewed journal of the American Cancer Society. Vitamin D has… Read More

#Cancer Research #News

Melanoma
#Cancer research #Melanoma #Skin cancer

Researchers slow down spread of melanoma 

Scientists from Tel Aviv University have deciphered the mechanism that enables skin cancer to metastasise to the brain and were able to delay the spread of the disease by 60-80% using existing treatments.  Once melanoma, or skin cancer, spreads to the brain, it becomes extremely aggressive. Patients… Read More

#Cancer Research #News